Christoph Baldegger, primary insider and member of the Board of Directors in
Hofseth BioCare ASA ("HBC") has today purchased 700,000 shares in HBC at an
average price of NOK 1.202837 per share.

As a result of the transaction, Mr. Baldegger holds 1,500,000 shares personally
and 1,747,853 shares indirectly through the Bonafide fund, in HBC equal to
approximately 0.82 % of the total outstanding A-shares with voting rights.

Please see the attached notification form for further information.

Contact:

Jon Olav Ødegård, CEO of Hofseth BioCare ASA
Phone: +47 936 32 966
E-mail: joo@hofsethbiocare.no

This information is subject to the disclosure requirements in the Market Abuse
Regulation EU 596/2014 article 19 number 3 and the Norwegian Securities Trading
Act section 5-12.
